12-aryl prostaglandin analogs

Details for Australian Patent Application No. 2005314000 (hide)

Owner Allergan, Inc.

Inventors Nguyen, Jeremiah H.; Donde, Yariv

Agent Davies Collison Cave

Pub. Number AU-B-2005314000

PCT Pub. Number WO2006/063179

Priority 11/009,298 10.12.04 US

Filing date 8 December 2005

Wipo publication date 15 June 2006

Acceptance publication date 14 June 2012

International Classifications

C07C 405/00 (2006.01) Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins

A61K 31/5575 (2006.01)

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

5 July 2007 PCT application entered the National Phase

  PCT publication WO2006/063179 Priority application(s): WO2006/063179

14 June 2012 Application Accepted

  Published as AU-B-2005314000

11 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005314003-Orthopic reconstituted human breast tumor model in mouse

2005313995-Compositions for binding to assay substrata and methods of using